Chronic pyridostigmine is antiarrhythmic in spontaneously hypertensive rats but detrimental in normotensive Wistar-Kyoto rats
Clinical Science · 10.06.2026 · 140 (6) · 883-904
DOI: 10.1042/cs20250921 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Science, online erschienen am 14.05.2026. Verfasst von Almos Boroš und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Hypertension, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 14200 Prague, Czech Republic. Hauptthemen laut MEDLINE: Pyridostigmine Bromide, Cholinesterase Inhibitors, Arrhythmias, Cardiac, Hypertension. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: Czech Science Foundation, National Institute for Research of Metabolic and Cardiovascular Diseases, Institute of Physiology, Czech Academy of Sciences.
Abstract (Originalsprache)
Spontaneously hypertensive rats (SHRs) are a model of genetic hypertension, cardiac hypertrophy, and autonomic nervous system imbalance. SHRs with transgenic constitutive expression of human C-reactive protein (SHR-CRP) exhibit chronic inflammation. We hypothesized that cholinergic potentiation prior to acute myocardial infarction would induce cardioprotection due to effects on heart contractility, vascular tone, and immunomodulation in both hypertensive strains. Male Wistar–Kyoto (WKY), SHR, and SHR-CRP rats were subjected to acute, short-term 2-week or long-term 8-week administration of pyridostigmine (peripheral acetylcholinesterase inhibitor). We evaluated blood pressure, heart rate, and cardiac parasympathetic tone. Myocardial infarction was induced in acutely and long-term treated rats. Moreover, arrhythmogenesis, blood pressure, and heart rate changes were assessed in short-term treated animals after acute adrenaline administration. Acute pyridostigmine administration reduced ischemic arrhythmogenesis in WKY rats. Short-term pyridostigmine reduced adrenaline-induced arrhythmogenesis in SHR rats but prolonged bradycardia due to atrio-ventricular conduction blockade. Moreover, it delayed blood pressure recovery after adrenaline administration in WKY rats to that of SHR. Long-term pyridostigmine treatment reduced ischemic arrhythmogenesis in SHRs, but prolonged ischemic tachyarrhythmia duration in WKY rats. This was associated with changes of cardiac connexin gene and protein expressions. It also tended to reduce infarct size in SHR-CRP rats. Long-term pyridostigmine treatment lowered rat CRP in plasma, MCP-1 protein expression in the left ventricle, and TNF-alpha protein expression in the spleen. Acetylcholinesterase inhibition by pyridostigmine provides positive cardiovascular effects in animals with autonomic nervous system imbalance and cardiovascular disease. However, it is not suitable for healthy animals or subjects due to possible adverse effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Experimental Hypertension, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 14200 Prague, Czech Republic.
- Faculty of Science, Charles University, Albertov 6, 128 00 Prague, Czech Republic.
- Laboratory of Developmental Cardiology, Institute of Physiology, Czech Academy of Sciences, Vídeňská 1083, 14200 Prague, Czech Republic.
ORCID-Profile: Almos Boroš, Ivana Vaněčkova, Jan Neckář, Josef Zicha
Förderung
- Czech Science Foundation
- National Institute for Research of Metabolic and Cardiovascular Diseases
- Institute of Physiology, Czech Academy of Sciences
Zitieren
APA
Boroš, A., Chalupová, M., Hrdlička, J., Vaněčkova, I., Řezáčová, L., Neckář, J., Zicha, J., & Behuliak, M. (2026). Chronic pyridostigmine is antiarrhythmic in spontaneously hypertensive rats but detrimental in normotensive Wistar-Kyoto rats. Clinical Science, 140(6), 883-904. https://doi.org/10.1042/cs20250921
Vancouver
Boroš A, Chalupová M, Hrdlička J, Vaněčkova I, Řezáčová L, Neckář J, et al. Chronic pyridostigmine is antiarrhythmic in spontaneously hypertensive rats but detrimental in normotensive Wistar-Kyoto rats. Clinical Science. 2026;140(6):883-904. doi:10.1042/cs20250921
BibTeX
@article{Boro2026,
author = {Boroš, Almos and Chalupová, Miloslava and Hrdlička, Jaroslav and Vaněčkova, Ivana and Řezáčová, Lenka and Neckář, Jan and Zicha, Josef and Behuliak, Michal},
title = {Chronic pyridostigmine is antiarrhythmic in spontaneously hypertensive rats but detrimental in normotensive Wistar-Kyoto rats},
journal = {Clinical Science},
year = {2026},
volume = {140},
number = {6},
pages = {883--904},
doi = {10.1042/cs20250921}
}
EUVIMED